Picture of Q BioMed logo

QBIO Q BioMed Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Q BioMed, fiscal year end - November 30th, USD millions except per share, conversion factor applied.

2018
November 30th
2019
November 30th
2020
November 30th
2021
November 30th
2022
November 30th
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
U
USG
Status:FinalFinalFinalFinalFinal
Cash
Cash and Short Term Investments2.680.1730.1770.3440.05
Net Total Accounts Receivable
Net Total Receivables0.080.012
Total Inventory
Prepaid Expenses
Total Current Assets2.70.190.2230.4590.072
Net Intangible Assets
Long Term Investments
Total Assets3.20.640.6230.8093.52
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities0.4295.241.75.498.13
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities3.35.691.75.498.13
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity-0.106-5.05-1.08-4.69-4.62
Total Liabilities & Shareholders' Equity3.20.640.6230.8093.52
Total Common Shares Outstanding
Total Preferred Shares Outstanding